The term epidemic keratoconjunctivitis was introduced by Hogan and Crawford (1942) when they described an outbreak of this disease, noting that epidemics had been reported previously in several European countries under a variety of different names. In 1955 the causative organism was identified as an adenovirus (Jawetz et al., 1955) , and since that time several different adenovirus serotypes have been shown to cause conjunctivitis with and without corneal involvement (Grayston et al., 1964 ). An outbreak in Bristol in 1971 caused by adenovirus type 8 has been described previously (Barnard et al., 1973) , and isolated cases and small outbreaks resulting from infections with types 10 and 19 have been diagnosed elsewhere (Heubner and Rowe, 1957 ; Desmyter et al., 1974; Burns and Potter, 1976; O'Day et al., 1976; Darougar et al., 1977; Zografos, 1977 All swabs were sent to the laboratory in 3 ml of milk saline transport medium; 0-2 ml aliquots of this medium were routinely inoculated into cultures of Hep2 and human embryo diploid fibroblasts (MRC 5) cells. Specimens which failed to yield a virus in these cultures were subsequently examined in cultures of human embryo kidney cells, and, if they were still negative, an aliquot of the original specimen was inoculated into organ cultures of human embryonic conjunctiva (Higgins and Scott, 1973 (Tullo and Higgins, 1978 An important subgroup consists of 4 patients who worked in a factory manufacturing electrical motors. The interval between the onset of symptoms in the first case and the other 3 was 7, 9, and 11 days respectively. One of this group was the factory nurse, who was exposed to infection when one of the other cases, a worker, reported to the first aid centre. This was the only instance of close contact between these patients, as, although all 4 patients knew each other, no other obvious point of contact, for example, common washing facilities, could be elicited.
SIGNS AND SYMPTOMS
The signs and symptoms of the majority of patients were typical of adenovirus keratoconjunctivitis. Patients generally complained of a painful, red, watering eye, sometimes accompanied by a foreign body sensation. Commonly symptoms were first noted on waking and increased in severity to reach a peak usually by the fourth or fifth day. The duration of these symptoms ranged from 10 days to 3 months, lasting 35 days on average. Six patients also complained of malaise and headache. Four patients complained of blurred vision, in each case related to corneal lesions, and 3 of these reported that the degree of visual disturbance varied from day to day. Visual acuity was temporarily reduced to 6/18 (corrected) in the more severely affected eye of each of 2 patients, but no patient has suffered persistent visual impairment.
Of the 19 cases 6 had signs and symptoms in 1 eye only; 4 had uniocular symptoms, but slit-lamp microscopy revealed evidence of involvement of the other eye. Nine patients had bilateral symptoms and signs, of whom only 1 was affected equally in both eyes. Examination of affected eyes indicated that the cornea and palpebral conjunctiva were characteristically involved (see Table 1 ).
Conjunctivitis. The papillary reactions was predominantly confined to the upper tarsal conjunctiva while follicles were recorded only in the lower fornix (Figs. 1 and 2) . Scarring of the conjunctiva occurred only in those patients who had previously had an inflammatory membrane (Table 1) .
Keratitis. There was corneal involvement in 13 of the 19 patients. One patient had a disciform keratitis. Eleven developed discrete stromal corneal opacities, of whom 7 had a previous or concurrent superficial punctate keratitis (Figs. 3 and 4) . Four Three patients merit further mention of their response to treatment. One, the brother of a patient seen during the acute stage, presented 6 weeks after the onset of symptoms because he had developed blurring of vision. Examination of the affected eye revealed a 'snow-storm'-like cornea with profuse stromal lesions (approximately 120). He was treated with betamethasone drops for 16 days and his vision improved from 6/9 to 6/5, by which time the lesions were scarcely discernible. He has suffered no further episodes of blurred vision.
The second patient was equally affected in both eyes, and 38 days after onset of symptoms he was left with 10 subepithelial opacities in each. Initially steroid therapy was restricted to 1 eye, the untreated eye serving as a control, but when the treated eye improved and the untreated deteriorated steroids were instilled into both eyes (Table 2) .
A third patient, first seen in January 1977, had developed subepithelial opacities by 3 weeks after the onset of symptoms and the visual acuity had fallen to 6/18 in each eye. With steroid therapy she improved, and when she was followed up 9 months later 8 stromal opacities were noted to have persisted in the central cornea of the right eye. The visual acuity was 6/9 and 6/5 in the right eye and left eye respectively. At this time she was experiencing intermittent blurring of vision in the right eye. She was last seen 18 months after the initial infection and still complained of bluiring of vision which gave rise to difficulties with her clerical job. Examination revealed a white eye with approximately 30 faint large opacities immediately subepithelially, mostly in the upper marginal cornea of the right eye. She had a Hudson-Stahli line in the right eye and a small central area of pigmentation in the left, neither of which was previously present.
Discussion
The epidemiological and clinical features of these adenovirus 10/19 infections were very similar to those found in 'classical' adenovirus keratoconjunctivitis caused by type 8 and more recently by type 19 (O'Day et al., 1976) . Spread of the 10/19 virus within the community was uncommon, with only 5% of the adults having antibodies, a similar proportion to that found previously in Bristol for type 8 adenovirus (Barnard et al., 1973) . This might be expected, as adenoviruses types 8, 10, and 19 all belong to the same subdivision, group IL, 1 of 4 groups into which adenoviruses are divided on their haemagglutination properties (Rosen, 1960) . The term 'epidemic keratoconjunctivitis' perhaps now justifies the inclusion of these serotypes rather than specifically referring to infections caused by serotype 8. Of other adenoviruses commonly associated with conjunctivitis types 3 and 7 belong to group I and type 4 to group III. None the less, the variation in severity of the symptoms and the lack of pathognomonic signs makes the accurate diagnosis of adenovirus follicular conjunctivitis difficult. Eleven such cases in this study were shown to be infections with agents other than the adenovirus type 10/19. The close correlation between the results of virus isolation and serology suggests that very few, if any, of the cases in which a diagnosis was not established were in fact infections with adenovirus 10/19.
The ease with which conjunctivitis caused by adenovirus type 8 can be spread, especially by medical personnel, is notorious (Thygeson, 1957; Dawson et al., 1972) . The relatively few secondary cases in this outbreak would indicate that the organism was of low virulence or, more probably, that preventive measures recommended previously , such as hand washing between examining patients, were effective.
While the constituent features of patients with this infection were typical of group It keratoconjunctivitis, the incidence and degree of chemosis was notably less than that sometimes seen in outbreaks caused by other serotypes . The proportion of patients who developed conjunctival scarring was high (Table 1) .
In this study the average interval from the onset of symptoms to the appearance of subepithelial opacities was 1 to 2 weeks. However, the interval to opacity-related symptoms may be considerably longer, as shown by the patient who presented for the first time 6 weeks after the initial infection complaining of blurred vision. Subepithelial opacities were always more pronounced in the eye in which symptoms developed first, and these lesions are liable to become more pronounced and numerous after the abrupt stoppage of steroids ( Table 2 ). The incidence of subepithelial lesions (58%) was lower than that described in infections caused by adenovirus type 8 (82%) (Barnard et al., 1973) .
It is thought that punctate subepithelial lesions result from the interaction of viral antigen and antibody in the anterior stroma, the cornea acting as a blotter (Jones, 1958) . At the time of infection the virus becomes established in the epithelium, producing a superficial punctate keratitis. Infective virus is seldom demonstrable after 10 to 14 days, but this does not exclude the continued production of viral antigens (Pereira, 1972) . That the epithelium is important in facilitating this antigenic stimulus is suggested by the fact that in patients with epithelial erosions the disease rarely progresses to the stage of typical subepithelial infiltrates (Laibson, 1975) .
The patient who developed a disciform keratitis is of considerable interest. She was the only patient to have neither follicles nor papillae. Not only are these unusual features of adenovirus infection, but she was the only patient to have had previous ocular disease. Although anterior uveitis occurs in adenovirus disease, the diagnostic rise in CF antibody titre to adenoviruses from < 1/8 during the development of the disciform keratitis suggests that the preceding uveitis had a different cause. Other investigations were negative. In the disciform keratitis of herpes simplex virus there is evidence of delayed hypersensitivity (Swyers et al., 1967) . However, it is not clear how the mechanisms producing discrete punctate stromal lesions and disciform keratitis differ; indeed, both may occur together (Hogan and Crawford, 1942) . On clinical grounds this patient was treated as a case of herpetic keratitis and given topical idoxuridine and lowdosage steroids. The diagnosis was made in retrospect on a rise in HAI antibodies. Gradual resolution took place over a period of 8 months, and she was left with a Hudson-Stahli line in the affected eye, but the cornea was otherwise normal. She was thus the second patient observed to develop such pigmentation during the late follow-up.
The response observed to the application of topical steroids substantiates previous reports of their usefulness in resolving subepithelial lesions (Dawson et al., 1972) . As it is rare for stromal opacities to occur without preceding superficial punctate keratitis, it is possible that many stromal lesions are preventable, although the use of prophylactic steroids with its attendant risks is debatable (Laibson et al., 1970) , and withdrawal of steroids may precipitate a recurrence of stromal opacities (Table 2) 
